公司資料
Zimmer Biomet 股價、新聞與催化劑
- 股票代碼:
- ZBH
- 交易所:
- NYSE
- 產業:
- MedTech
- 所在地:
- United States
股票表現
98.20 USD (-2.43%)
收盤價
最後更新: 2026年8月17日
16.2B USD
市值
股價為何變動
As of Aug 17, 2026, ZBH closed down 2.43% at $98.20. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Zimmer Biomet is a medical technology company focused on orthopedics, joint replacement, and musculoskeletal solutions. Its business is tied to procedure volumes and the adoption of implant and surgical systems.
所在地與產業分類
Headquartered in the United States and listed on NYSE, Zimmer Biomet has a global orthopedic footprint. It is a medtech company rather than a biotech name.
商業模式特徵
The business generates revenue through implants, surgical systems, and procedure-linked products. Investors watch joint-replacement demand, surgical volumes, product launches, and margin recovery.
生技產業定位
Zimmer Biomet sits outside biotech but inside the broader healthcare technology stack. It is influenced by procedure trends and device adoption, not by drug approvals or clinical readouts.
未來催化劑
- Zimmer Biomet should be watched for ROSA robotics adoption, hip and knee procedure growth, and continued product-cycle execution. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。